Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer. Schmid P, Cortes J, Dent R, McArthur H, et al. N Engl J Med 2024 Sep 15. doi: 10.1056/NEJMoa2409932.

Read + Share

Amedeo Smart

Independent Medical Education

Schmid P, Cortes J, Dent R, McArthur H, et al. Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer. N Engl J Med 2024 Sep 15. doi: 10.1056/NEJMoa2409932.
PMID: 39282906